In New Zealand, Centre of Adverse Reactions Monitoring (CARM) has received 88 reports of adverse reactions (ARs) associated with Rubifen SR [methylphenidate] between February and September 2007. Even though most of these reports were of reduced therapeutic effect, many patients, particularly ...
Official answer: Adzenys ER is an extended-release 1.25mg/mL liquid suspension compared to most other brands of amphetamine which are...
The article reports on the adverse effects of methylphenidate brand Rubifen SR. Case reports received by the New Zealand Centre of Adverse Reactions Monitoring (CARM) involved patients suffering from mood disorders, irritability, hallucinations suicidal and aggressive behavior and other unusual psychiatric...